Nothing to be concerned about.
“Slightly” now. What’s it going to be like a year from now?
ransomnote wrote: “I’m shocked that any mainstream publication is admitting to ANY issue. There are many severe problems with the ‘vaccines’ and they should have been pulled from the market long ago. I’m just glad to see the first MSM admission.”
Evidently, professionals disagree with your amateur assessment: “In the new paper, published Wednesday in the journal Nature Medicine, researchers from the U.K. and New Zealand said their findings shouldn’t change policies in the U.K. and elsewhere to continue deploying the AstraZeneca shot as a generally safe and effective tool against Covid-19. AstraZeneca and regulators have said they are studying the blood-clotting matter further and that the benefits of the shot outweigh risks for most people. AstraZeneca didn’t immediately comment on the new findings in the Nature study.”
Modified limited hangout.
209 reports of thrombocytopenic and thromboembolic cases, after 22 million first doses and 6.8 million second doses of the ChAdOx1 vaccine17...
In addition, 48% of patients with post-ChAdOx1 ITP had prior prescriptions that could induce ITP, compared to 35% of those who were unvaccinated at the time of their ITP event.
https://www.nature.com/articles/s41591-021-01408-4
a list of drugs that can cause ITP:
https://medicineworld.org/physicians/hematology/thrombocytopenia.html
I wonder if this is why women are reporting extended, painful period bleeding after the vaccination.